REQUEST A DEMO
Total
USD $0.00
Search more companies

Finesse Pharmaceuticals Private Limited (India)

Main Activities: Health Care and Social Assistance
Full name: Finesse Pharmaceuticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Finesse Pharmaceuticals Private Limited is an unlisted company, incorporated on 16/01/1985. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U85100GJ1985PTC007568 and registration number is 007568. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
827/6 C P Industrial Estate Santej - Rakanpur
Gandhinagar; Gujarat; Postal Code: 382721

Contact Details: Purchase the Finesse Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Finesse Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Finesse Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Finesse Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 16, 1985
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Finesse Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.11%
Total operating revenue
0.15%
Operating profit (EBIT)
14.84%
EBITDA
6.24%
Net Profit (Loss) for the Period
20.89%
Total Assets
-12.08%
Total Equity
56.42%
Operating Profit Margin (ROS)
0.63%
Net Profit Margin
0.53%
Return on Equity (ROE)
-10.6%
Debt/Equity
-118.22%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?